NCT07227038 Living Well With Advanced Breast Cancer
| NCT ID | NCT07227038 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ohio State University Comprehensive Cancer Center |
| Condition | Advanced Breast Carcinoma |
| Study Type | OBSERVATIONAL |
| Enrollment | 50 participants |
| Start Date | 2026-01-13 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 50 participants in total. It began in 2026-01-13 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study evaluates the use of supportive care in patients with advanced breast cancer to better understand what has helped them, what has been hard, and what kind of help they still need.
Eligibility Criteria
Inclusion Criteria: * \* COHORT 1: * Diagnosis of stage 4 metastatic breast cancer within the past 5 years * Never been referred to the LWABC * Adults age ≥ 18 years * COHORT 2: * Diagnosis of stage 4 metastatic breast cancer within the past 5 years * Have cancelled an appointment with the LWABC * Adults age ≥ 18 years * COHORT 3: * Been seen in the Medical Oncology Clinic at Stephanie Spielman Comprehensive Breast Center (SSCBC) within the past 5 years * Completed an appointment with the LWABC * Adults age ≥ 18 years * COHORT 4: * Caregivers for ABC patients * Adults age ≥ 18 years Exclusion Criteria: * Patients who cannot provide own informed consent
Contact & Investigator
The Ohio State University Comprehensive Cancer Center
✉ OSUCCCClinicaltrials@osumc.edu📞 800-293-5066
Ashley P Davenport, MD
PRINCIPAL INVESTIGATOR
Ohio State University Comprehensive Cancer Center
Frequently Asked Questions
Who can join the NCT07227038 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Advanced Breast Carcinoma. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07227038 currently recruiting?
Yes, NCT07227038 is actively recruiting participants. Contact the research team at OSUCCCClinicaltrials@osumc.edu for enrollment information.
Where is the NCT07227038 trial being conducted?
This trial is being conducted at Columbus, United States.
Who is sponsoring the NCT07227038 clinical trial?
NCT07227038 is sponsored by Ohio State University Comprehensive Cancer Center. The principal investigator is Ashley P Davenport, MD at Ohio State University Comprehensive Cancer Center. The trial plans to enroll 50 participants.